The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes.

Area of Science:

• Endocrinology
• Metabolic Diseases
• Clinical Practice Research

Background:

• Targeting body weight is an emerging, cost-effective alternative to hemoglobin A1c for diabetes management.
• Obesity and diabetes represent a growing epidemic in the United States, necessitating innovative clinical interventions.

Purpose of the Study:

• To evaluate the effectiveness of the 12-week multidisciplinary Weight Achievement and Intensive Treatment (WAIT) program for weight control and diabetes management.
• To assess the long-term maintenance of weight loss and diabetes control following the intervention.

Main Methods:

• The WAIT program is a 12-week multidisciplinary intervention focused on weight control and intensive diabetes management.
• The program is designed for routine clinical practice and includes continuous support for long-term maintenance.
• Participants' metabolic abnormalities, weight reduction, and medication needs were monitored.

Main Results:

• 82% of participants achieved a hemoglobin A1c target of less than 7% while reducing diabetes medications.
• Significant weight reduction was observed after 12 weeks and maintained for an additional year.
• The program effectively improved key metabolic abnormalities in diabetic patients.

Conclusions:

• The WAIT program demonstrates efficacy in improving metabolic health and achieving sustained weight loss in diabetic patients.
• Wider adoption of this intervention could help combat the obesity and diabetes epidemic.
• Endorsement by payers and governmental agencies is crucial for widespread dissemination.